Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Receivables - Other (2018 - 2025)

Historic Receivables - Other for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $8.5 million.

  • Health Catalyst's Receivables - Other rose 240.96% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 240.96%. This contributed to the annual value of $11.8 million for FY2024, which is 15106.38% up from last year.
  • As of Q3 2025, Health Catalyst's Receivables - Other stood at $8.5 million, which was up 240.96% from $8.7 million recorded in Q2 2025.
  • Health Catalyst's Receivables - Other's 5-year high stood at $11.8 million during Q4 2024, with a 5-year trough of $500000.0 in Q2 2022.
  • Over the past 5 years, Health Catalyst's median Receivables - Other value was $1.8 million (recorded in 2023), while the average stood at $3.8 million.
  • In the last 5 years, Health Catalyst's Receivables - Other crashed by 5833.33% in 2022 and then surged by 42222.22% in 2023.
  • Quarter analysis of 5 years shows Health Catalyst's Receivables - Other stood at $800000.0 in 2021, then rose by 12.5% to $900000.0 in 2022, then skyrocketed by 422.22% to $4.7 million in 2023, then skyrocketed by 151.06% to $11.8 million in 2024, then dropped by 27.97% to $8.5 million in 2025.
  • Its last three reported values are $8.5 million in Q3 2025, $8.7 million for Q2 2025, and $7.7 million during Q1 2025.